Jeremy M Levin insider trades

Open-market stock purchases and sales by Jeremy M Levin, Executive Chairman at Ovid Therapeutics Inc, from SEC Form 4 filings since Oct 1, 2010.

Track record: 40% of 5 scored buys are up 5% or more since purchase, averaging +8%.

Recent trades

DateStockTradeValue
Mar 23, 2026OVID Ovid Therapeutics IncBought (not open market)—
Feb 26, 2026OVID Ovid Therapeutics IncBought (not open market)—
Dec 15, 2025OVID Ovid Therapeutics IncBought (not open market)—
Dec 15, 2025OVID Ovid Therapeutics IncBought (not open market)—
Dec 11, 2025OVID Ovid Therapeutics IncBought—
Dec 11, 2025OVID Ovid Therapeutics IncBought$66.3K
Dec 11, 2025OVID Ovid Therapeutics IncBought$49.7K

Companies traded

  • OVID Ovid Therapeutics Inc: 7 buys, last Mar 23, 2026
  • BMY Bristol Myers Squibb Co: other filings, last Oct 1, 2011

Get free alerts when Jeremy M Levin files a new trade →